Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
- DOI
- 10.1007/s40744-021-00410-z
- Published
- 2021-12-30
- Container
- Rheumatology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-021-00410-z,
title = {Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials},
author = {Gerd R. Burmester and Kevin Winthrop and Ricardo Blanco and Peter Nash and Philippe Goupille and Valderilio F. Azevedo and Carlo Salvarani and Andrea Rubbert-Roth and Elizabeth Lesser and Ralph Lippe and Apinya Lertratanakul and Reva M. Mccaskill and John Liu and Eric M. Ruderman},
year = {2021},
journal = {Rheumatology and Therapy},
doi = {10.1007/s40744-021-00410-z},
url = {https://doi.org/10.1007/s40744-021-00410-z}
}RIS
TY - JOUR TI - Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials AU - Gerd R. Burmester AU - Kevin Winthrop AU - Ricardo Blanco AU - Peter Nash AU - Philippe Goupille AU - Valderilio F. Azevedo AU - Carlo Salvarani AU - Andrea Rubbert-Roth AU - Elizabeth Lesser AU - Ralph Lippe AU - Apinya Lertratanakul AU - Reva M. Mccaskill AU - John Liu AU - Eric M. Ruderman PY - 2021 JO - Rheumatology and Therapy DO - 10.1007/s40744-021-00410-z UR - https://doi.org/10.1007/s40744-021-00410-z ER -
APA
Burmester, G. R., Winthrop, K., Blanco, R., Nash, P., Goupille, P., Azevedo, V. F., Salvarani, C., Rubbert-Roth, A., Lesser, E., Lippe, R., Lertratanakul, A., Mccaskill, R. M., Liu, J., & Ruderman, E. M. (2021). Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials. Rheumatology and Therapy. https://doi.org/10.1007/s40744-021-00410-z
Source records
- crossref · retrieved 2026-11-06T07:56:27.320Z